About the Webcast
Dana-Farber/Brigham and Women’s Cancer Center Experts Webcast 10th Annual Patient Education Event on Prostate Cancer
Boston, MA – On September 10, 2008, at 6 p.m. E.T., leading prostate cancer specialists from Dana-Farber/Brigham and Women’s Cancer Center will webcast their 10th Annual Symposium on Prostate Cancer, a patient education event featuring the newest advances in treatment, screening, and prevention of prostate cancer.
For this webcast, Anthony V. D’Amico, MD, PhD, Chief of the Prostate Cancer Radiation Oncology Service, Philip W. Kantoff, MD, Director of the Lank Center for Genitourinary Oncology, Jerome P. Richie, MD, Chief of Urologic Surgery, and Jim C. Hu, MD, MPH, Director of Minimally Invasive Urologic Oncology, will discuss the latest approaches and research in the prevention, diagnosis, and treatment of prostate cancer.
The Symposium will provide an overview of new treatment advances and related outcomes, including new medical therapies, radioactive seed implantation techniques, robotic-assisted surgery, nerve-sparing techniques, image-guided radiation therapy approaches, and the most recent results of clinical trials. Also, the latest findings in the genetics of prostate cancer and prostate cancer screening guidelines will be discussed.
The second most common cancer in men, prostate cancer is most often diagnosed in men over the age of 50. The National Cancer Institute estimates more than 186,000 new cases of prostate cancer in the United States in 2008, and more than 28,000 deaths from the disease. More common in African-American men than in Caucasian men, studies have also shown that a man’s risk is doubled if his father or brother has the disease.
See the latest news from Brigham and Women’s Hospital.
Brigham and Women's Hospital (BWH) is a 777-bed nonprofit teaching affiliate of Harvard Medical School and a founding member of Partners HealthCare, an integrated health care delivery network. In July of 2008, the hospital opened the Carl J. and Ruth Shapiro Cardiovascular Center, the most advanced center of its kind. BWH is committed to excellence in patient care with expertise in virtually every specialty of medicine and surgery. The BWH medical preeminence dates back to 1832, and today that rich history in clinical care is coupled with its national leadership in quality improvement and patient safety initiatives and its dedication to educating and training the next generation of health care professionals. Through investigation and discovery conducted at its Biomedical Research Institute (BRI), BWH is an international leader in basic, clinical and translational research on human diseases, involving more than 860 physician-investigators and renowned biomedical scientists and faculty supported by more than $416 M in funding. BWH is also home to major landmark epidemiologic population studies, including the Nurses' and Physicians' Health Studies and the Women's Health Initiative. For more information about BWH, please visit www.brighamandwomens.org